Blog

FDA Approves Groundbreaking Gene Therapy for Cancer – MIT Technology Review


MIT Technology Review

FDA Approves Groundbreaking Gene Therapy for Cancer
MIT Technology Review
A revolutionary cancer therapy that uses genetically engineered immune cells has been approved by the U.S. Food and Drug Administration, ushering in a new era of cancer treatment. The FDA calls the treatment, made by Novartis, the “first gene therapy
FDA approval brings first gene therapy to the United StatesFDA.gov


FDA Approves First Gene Therapy For LeukemiaNPR
FDA announces first US gene therapy approval for cancer treatmentCNN
PBS NewsHour –National Cancer Institute
all 656 news articles »

2017-08-31 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.